150 related articles for article (PubMed ID: 33455846)
1. Prognostic impact of electrocardiographic left ventricular hypertrophy following transcatheter aortic valve replacement.
Tanaka T; Yahagi K; Asami M; Ninomiya K; Kikushima H; Okuno T; Horiuchi Y; Yuzawa H; Komiyama K; Tanaka J; Yokozuka M; Miura S; Aoki J; Tanabe K
J Cardiol; 2021 Apr; 77(4):346-352. PubMed ID: 33455846
[TBL] [Abstract][Full Text] [Related]
2. Implication of Different ECG Left Ventricular Hypertrophy in Patients Undergoing Transcatheter Aortic Valve Replacement.
Yang Y; Ahn JM; Kang DY; Ko E; Kim S; Kim TO; Kim JH; Lee J; Lee SA; Kim DH; Kim HJ; Kim JB; Choo SJ; Park SJ; Park DW
J Am Heart Assoc; 2022 Feb; 11(4):e023647. PubMed ID: 35112886
[TBL] [Abstract][Full Text] [Related]
3. The relationship between electrocardiographic left ventricular hypertrophy criteria and echocardiographic mass in patients undergoing transcatheter aortic valve replacement.
Sjöberg S; Sundh F; Schlegel T; Maynard C; Rück A; Wagner G; Ugander M
J Electrocardiol; 2015; 48(4):630-6. PubMed ID: 25865909
[TBL] [Abstract][Full Text] [Related]
4. Clinical value of regression of electrocardiographic left ventricular hypertrophy after aortic valve replacement.
Yamabe S; Dohi Y; Higashi A; Kinoshita H; Sada Y; Hidaka T; Kurisu S; Shiode N; Kihara Y;
Heart Vessels; 2016 Sep; 31(9):1497-503. PubMed ID: 26531830
[TBL] [Abstract][Full Text] [Related]
5. Absence of electrocardiographic left ventricular hypertrophy is associated with increased mortality after transcatheter aortic valve replacement.
Kampaktsis PN; Ullal AV; Swaminathan RV; Minutello RM; Kim L; Bergman GS; Feldman DN; Singh H; Wong SC; Okin PM
Clin Cardiol; 2018 Sep; 41(9):1246-1251. PubMed ID: 30062778
[TBL] [Abstract][Full Text] [Related]
6. Left Ventricular Hypertrophy Does Not Affect 1-Year Clinical Outcomes in Patients Undergoing Transcatheter Aortic Valve Replacement.
Varshney AS; Manandhar P; Vemulapalli S; Kirtane AJ; Mathew V; Shah B; Lowenstern A; Kosinski AS; Kaneko T; Thourani VH; Bhatt DL
JACC Cardiovasc Interv; 2019 Feb; 12(4):373-382. PubMed ID: 30784643
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Value of Electrocardiographic Left Ventricular Hypertrophy After Transcatheter Aortic Valve Implantation: Insights from the OCEAN-TAVI Registry.
Koga M; Izumo M; Yoneyama K; Akashi YJ; Yashima F; Tada N; Yamawaki M; Shirai S; Naganuma T; Yamanaka F; Ueno H; Tabata M; Mizutani K; Takagi K; Watanabe Y; Yamamoto M; Hayashida K;
Am J Cardiol; 2023 Oct; 204():130-139. PubMed ID: 37541149
[TBL] [Abstract][Full Text] [Related]
8. Left Ventricular Hypertrophy and Clinical Outcomes Over 5 Years After TAVR: An Analysis of the PARTNER Trials and Registries.
Gonzales H; Douglas PS; Pibarot P; Hahn RT; Khalique OK; Jaber WA; Cremer P; Weissman NJ; Asch FM; Zhang Y; Gertz ZM; Elmariah S; Clavel MA; Thourani VH; Daubert M; Alu MC; Leon MB; Lindman BR
JACC Cardiovasc Interv; 2020 Jun; 13(11):1329-1339. PubMed ID: 32499024
[TBL] [Abstract][Full Text] [Related]
9. Prognostic implications of residual left ventricular hypertrophy and systolic dysfunction in aortic stenosis following transcatheter aortic valve replacement.
Pedersen ALD; Povlsen JA; Rasmussen VG; Frederiksen CA; Christiansen EH; Terkelsen CJ; Vase H; Poulsen SH
Int J Cardiovasc Imaging; 2023 Jan; 39(1):13-22. PubMed ID: 36598683
[TBL] [Abstract][Full Text] [Related]
10. Absence of electrocardiographic left ventricular hypertrophy in patients undergoing Transcatheter aortic valve replacement is associated with increased mortality.
Zhang R; Jou S; Cao Y; Keller K; Xiao E; de La Rosa A; DeLago A; El-Hajjar M; Torosoff M
J Electrocardiol; 2020; 63():12-16. PubMed ID: 33017756
[TBL] [Abstract][Full Text] [Related]
11. Absence of electrocardiographic left ventricular hypertrophy and poor outcome in patients undergoing transcatheter aortic valve replacement-A systematic review and meta-analysis.
Martha JW; Pranata R; Yonas E; Wibowo A; Akbar MR
J Card Surg; 2021 Jul; 36(7):2233-2239. PubMed ID: 33768590
[TBL] [Abstract][Full Text] [Related]
12. Prognostic impact of arterial stiffness following transcatheter aortic valve replacement.
Tanaka T; Asami M; Yahagi K; Ninomiya K; Okuno T; Horiuchi Y; Komiyama K; Tanaka J; Yokozuka M; Miura S; Aoki J; Tanabe K
J Cardiol; 2021 Jul; 78(1):37-43. PubMed ID: 33516637
[TBL] [Abstract][Full Text] [Related]
13. Prognostic impact of left ventricular mass regression after transcatheter aortic valve replacement in patients with left ventricular hypertrophy.
Oh JK; Lee SH; Lee SA; Kang DY; Lee S; Kim HJ; Ahn JM; Kim JB; Park DW; Song JM; Choo SJ; Kang DH; Song JK; Park SJ; Kim DH
Int J Cardiol; 2021 Jun; 332():60-66. PubMed ID: 33781852
[TBL] [Abstract][Full Text] [Related]
14. Regression of Electrocardiographic Left Ventricular Hypertrophy After Transcatheter Aortic Valve Implantation for Aortic Stenosis.
Tobe A; Tanaka A; Tokuda Y; Akita S; Fujii T; Miki Y; Furusawa K; Ishii H; Usui A; Murohara T
Circ J; 2021 Jun; 85(7):1093-1098. PubMed ID: 34039838
[TBL] [Abstract][Full Text] [Related]
15. Clinical implications of electrocardiographic left ventricular strain and hypertrophy in asymptomatic patients with aortic stenosis: the Simvastatin and Ezetimibe in Aortic Stenosis study.
Greve AM; Boman K; Gohlke-Baerwolf C; Kesäniemi YA; Nienaber C; Ray S; Egstrup K; Rossebø AB; Devereux RB; Køber L; Willenheimer R; Wachtell K
Circulation; 2012 Jan; 125(2):346-53. PubMed ID: 22147903
[TBL] [Abstract][Full Text] [Related]
16. Regression of Left Ventricular Mass After Transcatheter Aortic Valve Replacement: The PARTNER Trials and Registries.
Chau KH; Douglas PS; Pibarot P; Hahn RT; Khalique OK; Jaber WA; Cremer P; Weissman NJ; Asch FM; Zhang Y; Gertz ZM; Elmariah S; Clavel MA; Thourani VH; Daubert M; Alu MC; Leon MB; Lindman BR
J Am Coll Cardiol; 2020 May; 75(19):2446-2458. PubMed ID: 32408979
[TBL] [Abstract][Full Text] [Related]
17. Regression of electrocardiographic left ventricular hypertrophy or strain is associated with lower incidence of cardiovascular morbidity and mortality in hypertensive patients independent of blood pressure reduction - A LIFE review.
Bang CN; Devereux RB; Okin PM
J Electrocardiol; 2014; 47(5):630-5. PubMed ID: 25052475
[TBL] [Abstract][Full Text] [Related]
18. Serial evaluation of electrocardiographic left ventricular hypertrophy for prediction of risk in hypertensive patients.
Okin PM
J Electrocardiol; 2009; 42(6):584-8. PubMed ID: 19631946
[TBL] [Abstract][Full Text] [Related]
19. Left ventricular hypertrophy as a predictor of cardiovascular outcomes after transcatheter aortic valve replacement.
Ito N; Zen K; Takahara M; Tani R; Nakamura S; Fujimoto T; Takamatsu K; Yashige M; Kadoya Y; Yamano M; Yamano T; Nakamura T; Yaku H; Matoba S
ESC Heart Fail; 2023 Apr; 10(2):1336-1346. PubMed ID: 36725669
[TBL] [Abstract][Full Text] [Related]
20. Impact of transcatheter aortic valve replacement on left ventricular hypertrophy, diastolic dysfunction and quality of life in patients with preserved left ventricular function.
Dahiya G; Kyvernitakis A; Joshi AA; Lasorda DM; Bailey SH; Raina A; Biederman RWW; Kanwar MK
Int J Cardiovasc Imaging; 2021 Feb; 37(2):485-492. PubMed ID: 32902782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
